🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jay M. Sosenko

University of Miami

ORCID: 0000-0002-7204-8367

Also affiliated with Global Institutes on Addictions

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.443Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study

Diabetes Care(2025)10.2337/dc25-0192
Top 42%
0.443DataRank
Top 42%15 citations

Lauric Ferrat, Nicholas J. Thomas, Cate Speake, Diane K. Wherrett, Jennifer L. Sherr +10 more

Papers

Driven by 18 papers — median percentile 58. Top paper: “Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes”.

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Diabetes Care(2021)10.2337/dc21-0944
N/A
1.3DataRank · unranked
33 citations

María J. Redondo, Heba M. Ismail, Laura M. Jacobsen, Emily K. Sims, Jerry P. Palmer +5 more

The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk

Diabetes Care(2022)10.2337/dc22-0167
N/A
0.558DataRank · unranked
7 citations

David Cuthbertson, Stephen E. Gitelman, Jay S. Skyler, Andrea K. Steck, Henry Rodriguez +9 more

Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study

Diabetes Care(2025)10.2337/dc25-0192
Top 42%
0.443DataRank
Top 42%15 citations

Lauric Ferrat, Nicholas J. Thomas, Cate Speake, Diane K. Wherrett, Jennifer L. Sherr +10 more

Index60 as an additional diagnostic criterion for type 1 diabetes

Diabetologia(2021)10.1007/s00125-020-05365-4
N/A
0DataRank · unranked
27 citations

Brandon M. Nathan, Laura M. Jacobsen, Emily K. Sims, Laura E. Bocchino, Alberto Pugliese +8 more

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac285
N/A
0DataRank · unranked
11 citations

Megan Warnock, Ping Xu, Susan Geyer, Jennifer B. Marks, Antoinette Moran +3 more

Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening

Diabetes Care(2022)10.2337/dc22-1362
N/A
0DataRank · unranked
6 citations

David Cuthbertson, Jamie L. Felton, Heba M. Ismail, Brandon M. Nathan, Laura M. Jacobsen +10 more

Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac440
N/A
0DataRank · unranked
8 citations

Brian N. Bundy, Heba M. Ismail, Mark A. Clements, Megan Warnock, Susan Geyer +3 more

Time to reframe the disease staging system for type 1 diabetes

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00239-0
N/A
0DataRank · unranked
10 citations

Mark A. Atkinson, Jay M. Sosenko, Stephen E. Gitelman, Laura M. Jacobsen

Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes

Diabetologia(2024)10.1007/s00125-024-06338-7
N/A
0DataRank · unranked
8 citations

David Cuthbertson, Andrea K. Steck, Kevan C. Herold, Richard A. Oram, Mark A. Atkinson +8 more

Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae048
N/A
0DataRank · unranked
8 citations

David Cuthbertson, Laura M. Jacobsen, Heba M. Ismail, Brandon M. Nathan, Kevan C. Herold +3 more

Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes Care(2024)10.2337/dc24-0171
N/A
0DataRank · unranked
6 citations

David Cuthbertson, Brian N. Bundy, Mark A. Atkinson, Wayne D. Moore, Michael J. Haller +13 more

Effect of Oral Insulin on Early Combined Glucose and C‐Peptide Endpoints in Individuals at High‐Risk for Type 1 Diabetes

Pediatric Diabetes(2024)10.1155/2024/8343868
N/A
0DataRank · unranked
1 citations

Laura M. Jacobsen, David Cuthbertson, Emily K. Sims, Heba M. Ismail, María J. Redondo +8 more

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes

Diabetes(2025)10.2337/db25-0801
N/A
0DataRank · unranked
2 citations

Alice L. J. Carr, Peter Taylor, J Bonet, David Cuthbertson, Jay M. Sosenko +13 more

Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval

Diabetes(2025)10.2337/db25-0310
N/A
0DataRank · unranked
1 citations

William E. Russell, David Cuthbertson, Jay S. Skyler, Laura M. Jacobsen, Heba M. Ismail +9 more

The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa055
N/A
0DataRank · unranked
7 citations

Catherine C. Cowie, Jay M. Sosenko, Kara Mizokami‐Stout, Andrew J.M. Boulton, Rodica Pop‐Busui +1 more

A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts

Diabetes Technology & Therapeutics(2025)10.1089/dia.2024.0422
N/A
0DataRank · unranked
1 citations

David Cuthbertson, Laura M. Jacobsen, María J. Redondo, Emily K. Sims, Heba M. Ismail +5 more

The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa348
N/A
0DataRank · unranked
7 citations

Mario A. Cleves, Jay M. Sosenko, Ingrid Libman, David A. Baidal, Ashok Balasubramanyam +80 more

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants

Diabetologia(2021)10.1007/s00125-021-05573-6
N/A
0DataRank · unranked
9 citations

David Cuthbertson, Megan Warnock, Kuldeep Lohano, Farah Meah, John M. Wentworth +4 more